Fabros, Loreta .

HRN: 23-01-67  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2023
CEFTRIAXONE 1G (VIAL)
05/11/2023
05/18/2023
IV
2g
OD
Sepsis
Waiting Final Action 
05/14/2023
METRONIDAZOLE 500MG (TAB)
05/14/2023
05/20/2023
ORAL
500mg
TID
Acute Gastroenteritis
Waiting Final Action 
05/11/2023
MUPIROCIN 2%, 15G (TUBE)
05/20/2023
05/27/2023
TOPICAL
2%
BID
Avulsed Wound At Left Arm
Checking Final Appropriateness 
06/04/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/04/2023
06/11/2023
IV
1.5
Q8
Aspiration Pneumonia
Waiting Final Action 
06/05/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/05/2023
06/11/2023
TOPICAL
1%
TID
Decubitus Ulcer
Waiting Final Action 
06/06/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/06/2023
06/13/2023
TOPICAL
1%
TID
Decubitus Ulcer
Waiting Final Action 
06/10/2023
LEVOFLOXACIN 500MG (TAB)
06/10/2023
06/16/2023
PO
500mg
OD
CAP MR, UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: